Congenital generalized lipodystrophy

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

2 events
May 2026A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait

Novartis Pharmaceuticals

TrialNOT YET RECRUITING
Feb 2019Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

University of Liege — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Congenital generalized lipodystrophy.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

MYALEPT

(metreleptin)Orphan drugstandard

Chiesi Farmaceutici S.p.A.

Leptin Analog [EPC]

12.1 Mechanism of Action Adipocytes store lipids to meet the fuel requirements of non-adipose tissues during fasting. In patients with generalized lip...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Congenital generalized lipodystrophy.
Search all trials →
Search clinical trials for Congenital generalized lipodystrophy

Recent News & Research

No recent news articles indexed yet for Congenital generalized lipodystrophy.
Search PubMed for Congenital generalized lipodystrophy

Browse all Congenital generalized lipodystrophy news →

Specialist Network

Top 6 by expertise

View all Congenital generalized lipodystrophy specialists →

Quick Actions